http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110684833-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_701a52f39ae008850bbaba35d9f0027d |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6869 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6869 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883 |
filingDate | 2019-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45c0669fc1858fe43e7e83140452425a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8b2387d4266ed185480e1bd698ae4c3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45ddbca28448af78dd41a691e4d8bd9f |
publicationDate | 2020-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-110684833-A |
titleOfInvention | A genetic testing method for evaluating individual sensitivity and side effects of ovulation induction drugs |
abstract | The invention provides a gene detection method for individual sensitivity and side effects of ovulation induction drugs, comprising the following steps: (1) extracting sample genomic DNA, quantification and quality inspection; (2) performing multiple target gene variants after passing the quality inspection Amplification of sites or enrichment of target genes with specific nucleic acid probes. According to the number of target genes and sites detected, an appropriate amount of amplification products that have passed the quality inspection are taken for first-generation sequencing, and first-generation sequencing is used for specific sites. Amplification and detection; (3) According to the number of target genes and loci to be detected, take an appropriate amount of amplification products that have passed the quality inspection, carry out next-generation sequencing or gene chip analysis, sequence the multiple PCR products, and split the off-machine data. Perform bioinformatics analysis to output SNPs of specific genes; (4) analyze and interpret through the pharmacogenome database and eugenics gene database, and output personalized and precise ovulation induction drug recommendations and programs. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111471753-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112553306-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111500723-A |
priorityDate | 2019-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 133.